Patel N, Herbert L, Green TD. The emotional, social, and financial burden of food allergies on children and their families. Allergy Asthma Proc. 2017;38(2):88–91.

Article  PubMed  Google Scholar 

Bilaver LA, Chadha AS, Doshi P, O’Dwyer L, Gupta RS. Economic burden of food allergy: a systematic review. Ann Allergy Asthma Immunol. 2019;122(4):373-380.e1.

Article  PubMed  Google Scholar 

Peters RL, Krawiec M, Koplin JJ, Santos AF. Update on food allergy. Pediat Allergy Immunol. 2021;32(4):647–57.

Article  Google Scholar 

Calvani M, Bianchi A, Imondi C, Romeo E. Oral desensitization in IgE-mediated food allergy: effectiveness and safety. Pediatr Allergy Immunol. 2020;31:49–50.

Article  PubMed  Google Scholar 

Nowak-Wegrzyn A, Sato S, Fiocchi A, Ebisawa M. Oral and sublingual immunotherapy for food allergy. Curr Opin Allergy Clin Immunol. 2019;19(6):606–13.

Article  CAS  PubMed  Google Scholar 

Blumchen K, Trendelenburg V, Ahrens F, Gruebl A, Hamelmann E, Hansen G, et al. Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol Pract. 2019;7(2):479-491.e10.

Article  PubMed  Google Scholar 

Epstein-Rigbi N, Goldberg MR, Levy MB, Nachshon L, Elizur A. Quality of life of children aged 8–12 years undergoing food allergy oral immunotherapy: child and parent perspective. Allergy. 2020;75(10):2623–32.

Article  PubMed  Google Scholar 

Epstein-Rigbi N, Goldberg MR, Levy MB, Nachshon L, Elizur A. Quality of life of food-allergic patients before, during, and after oral immunotherapy. J Allergy Clin Immunol Pract. 2019;7(2):429-436.e2.

Article  PubMed  Google Scholar 

Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73(4):799–815.

Article  CAS  PubMed  Google Scholar 

Bégin P, Chan ES, Kim H, Wagner M, Favron-Godbout C, Abrams EM, et al. CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy. Allergy Asthma Clin Immunol. 2020;16:20.

Article  PubMed  PubMed Central  Google Scholar 

Epstein-Rigbi N, Levy MB, Nachshon L, Koren Y, Katz Y, Goldberg MR, et al. Efficacy and safety of food allergy oral immunotherapy in adults. Allergy. 2023;78(3):803–11.

Article  CAS  PubMed  Google Scholar 

Bird JA, Spergel JM, Jones SM, Rachid R, Assa’ad AH, Wang J, et al. Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial. J Allergy Clin Immunol Pract. 2018;6(2):476-485.e3.

Article  PubMed  Google Scholar 

Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2017;72(8):1133–47.

Article  CAS  PubMed  Google Scholar 

Rigbi NE, Goldberg MR, Levy MB, Nachshon L, Golobov K, Elizur A. Changes in patient quality of life during oral immunotherapy for food allergy. Allergy. 2017;72(12):1883–90.

Article  CAS  PubMed  Google Scholar 

Sicherer SH, Warren CM, Dant C, Gupta RS, Nadeau KC. Food allergy from infancy through adulthood. J Allergy Clin Immunol Pract. 2020;8(6):1854–64.

Article  PubMed  PubMed Central  Google Scholar 

Elizur A, Appel MY, Goldberg MR, Yichie T, Levy MB, Nachshon L, et al. Clinical and laboratory 2-year outcome of oral immunotherapy in patients with cow’s milk allergy. Allergy. 2016;71(2):275–8.

Article  CAS  PubMed  Google Scholar 

Nachshon L, Goldberg MR, Levy MB, Appel MY, Epstein-Rigbi N, Lidholm J, et al. Efficacy and safety of sesame oral immunotherapy-a real-world, single-center study. J Allergy Clin Immunol Pract. 2019;7(8):2775-2781.e2.

Article  PubMed  Google Scholar 

Nachshon L, Goldberg MR, Katz Y, Levy MB, Elizur A. Long-term outcome of peanut oral immunotherapy-real-life experience. Pediatr Allergy Immunol. 2018;29(5):519–26.

Article  PubMed  Google Scholar 

Elizur A, Appel MY, Nachshon L, Levy MB, Epstein-Rigbi N, Pontoppidan B, et al. Walnut oral immunotherapy for desensitisation of walnut and additional tree nut allergies (Nut CRACKER): a single-centre, prospective cohort study. Lancet Child Adolesc Health. 2019;3(5):312–21.

Article  PubMed  Google Scholar 

Elizur A, Appel MY, Nachshon L, Levy MB, Epstein-Rigbi N, Koren Y, et al. Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study). Allergy. 2022;77(6):1863–72.

Article  CAS  PubMed  Google Scholar 

Levy MB, Elizur A, Goldberg MR, Nachshon L, Katz Y. Clinical predictors for favorable outcomes in an oral immunotherapy program for IgE-mediated cow’s milk allergy. Ann Allergy Asthma Immunol. 2014;112(1):58-63.e1.

Article  CAS  PubMed  Google Scholar 

Flokstra-De Blok BMJ, Van Der Meulen GN, Dunngalvin A, Vlieg-Boerstra BJ, Oude Elberink JNG, Duiverman EJ, et al. Development and validation of the food allergy quality of life questionnaire—adult form. Allergy. 2009;64(8):1209–17.

Article  CAS  PubMed  Google Scholar 

Nachshon L, Goldberg MR, Elizur A, Levy MB, Schwartz N, Katz Y. A Web site-based reporting system for monitoring home treatment during oral immunotherapy for food allergy. Ann Allergy Asthma Immunol. 2015;114(6):510–5.

Article  PubMed  Google Scholar 

Van Der Velde JL, Flokstra-De Blok BMJ, Vlieg-Boerstra BJ, Oude Elberink JNG, Dunngalvin A, Hourihane JO, et al. Development, validity and reliability of the food allergy independent measure (FAIM). Allergy. 2010;65(5):630–5.

Article  PubMed  Google Scholar 

WHO. Process of translation and adaptation of instruments. J Investig Allergol Clin Immunol. 2017;27(6):363–369. https://terrance.who.int/mediacentre/data/WHODAS/Guidelines/WHODAS%202.0%20Translation%20guidelines.pdf & https://doi.org/10.18176/jiaci.0182. Accessed 28 Jun 2017.

Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–15.

Article  CAS  PubMed  Google Scholar 

Goossens NJ, Flokstra-De Blok BMJ, Van Der Meulen GN, Arnlind MH, Asero R, Barreales L, et al. Health-related quality of life in food-allergic adults from eight European countries. Ann Allergy Asthma Immunol. 2014;113(1):63-68.e1.

Article  PubMed  Google Scholar 

Stensgaard A, Bindslev-Jensen C, Nielsen D, Munch M, DunnGalvin A. Quality of life in childhood, adolescence and adult food allergy: patient and parent perspectives. Clin Exp Allergy. 2017;47(4):530–9.

Article  CAS  PubMed  Google Scholar 

Goossens NJ, Flokstra-de Blok BMJ, Vlieg-Boerstra BJ, Duiverman EJ, Weiss CC, Furlong TJ, et al. Online version of the food allergy quality of life questionnaire-adult form: validity, feasibility and cross-cultural comparison. Clin Exp Allergy. 2011;41(4):574–81.

Article  CAS  PubMed  Google Scholar 

Elizur A, Goldberg MR, Levy MB, Nachshon L, Katz Y. Oral immunotherapy in cow’s milk allergic patients: course and long-term outcome according to asthma status. Ann Allergy Asthma Immunol. 2015;114(3):240-244.e1.

Article  CAS  PubMed  Google Scholar 

Soller L, Carr S, Kapur S, Rex GA, McHenry M, Cook VE, et al. Real-world peanut OIT in infants may be safer than non-infant preschool OIT and equally effective. J Allergy Clin Immunol Pract. 2022;10(4):1113-1116.e1.

Article  PubMed  Google Scholar 

Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, et al. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017;139(1):173-181.e8.

Article  CAS  PubMed  Google Scholar 

Factor JM, Mendelson L, Lee J, Nouman G, Lester MR. Effect of oral immunotherapy to peanut on food-specific quality of life. Ann Allergy Asthma Immunol. 2012;109(5):348-352.e2.

Article